Eptifibatide: Clinical Trials

5 trials of Eptifibatide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Terminated 2, Unknown 1

Follow Eptifibatide: new trials by email Literature Review of Eptifibatide trials Research Report on Eptifibatide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)
Eptifibatide - Coronary Artery Disease
Phase 4TerminatedUniversity of Turin, Italy912007-10-012011-10-19
Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty
eptifibatide - Angioplasty
Phase 4TerminatedBrigham and Women's Hospital12002006-03-012007-07-20
Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
Bivalirudin with and without eptifibatide - Coronary Artery Disease
Phase 4UnknownLifeBridge Health2002006-03-012006-08-30
Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
Eptifibatide, Placebo - Non ST Elevation Myocardial Infarction
Phase 4CompletedMedical University of Silesia1402005-01-012013-10-31
BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention
eptifibatide - Coronary Artery Disease, Myocardial Infarction
Phase 4CompletedCardiology Research UBC6242004-12-012013-11-28

Conditions studied

Coronary Artery Disease (3)  ·  Myocardial Infarction (2)  ·  Non-ST Elevated Myocardial Infarction (1)

Sponsors

Brigham and Women's Hospital (1)  ·  Cardiology Research UBC (1)  ·  LifeBridge Health (1)  ·  Medical University of Silesia (1)  ·  University of Turin, Italy (1)

Countries

United States (3)  ·  Canada (1)  ·  Italy (1)  ·  Poland (1)

Top investigators

Anthony Fung, MB,BS, FRCPC (1)  ·  Daniel I Simon, MD (1)  ·  Miroslaw Wilczynski, MD, PhD (1)  ·  Paul A Gurbel, MD (1)

Results publications

PMID 19232896, PMID 19264239, PMID 19463380, PMID 19706858, PMID 22607870, PMID 23392654